Cargando…
Potential bias in ophthalmic pharmaceutical clinical trials
To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study short...
Autor principal: | Varner, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693990/ https://www.ncbi.nlm.nih.gov/pubmed/19668731 |
Ejemplares similares
-
Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs
por: Chilet-Rosell, Elisa
Publicado: (2014) -
Exploring the Potential of Nanoporous Materials for Advancing Ophthalmic Treatments
por: Wu, Kevin Y., et al.
Publicado: (2023) -
Pharmaceutical regulation of telomerase and its clinical potential
por: Sprouse, Alyssa A, et al.
Publicado: (2012) -
Recent Advances and the Potential for Clinical Use of Autofluorescence Detection of Extra-Ophthalmic Tissues
por: Wizenty, Jonas, et al.
Publicado: (2020) -
Role of Ophthalmic Nurses in Prevention of Ophthalmic Diseases
por: Hadavand, Mohammad Bagher, et al.
Publicado: (2013)